Increased Glucagon Immunoreactivity in a Rat Model of Diet-Induced Obesity following Sleeve Gastrectomy
Medical Principles and Practice · 2023
DOI: 10.1159/000533746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Principles and Practice, 2023. Verfasst von Suleiman Al-Sabah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Medicine, Kuwait University, Kuwait City, Kuwait, sulaiman.alsabah@ku.edu.kw. Hauptthemen laut MEDLINE: Gastrectomy, Obesity, Glucagon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Bariatric surgery is currently the most effective treatment for obesity, and procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy (SG) also result in rapid improvements in insulin sensitivity and glucose tolerance. In addition, these procedures cause changes in the secretion of various gut-derived hormones. The role these hormones play in the mechanism of the beneficial effects of bariatric surgery is still debated, but nonetheless, their importance provides inspiration for novel obesity-targeted pharmacotherapies.
Methods
Male Sprague-Dawley rats were fed either regular chow or a cafeteria diet to induce obesity. A sub-group of the obese animals then underwent either sham surgery or SG.
Results
Following a 4-week recovery period, SG rats weighed significantly less than obese or sham-operated rats. Improvements in glucose tolerance and insulin sensitivity also occurred in the SG group, but these were not always statistically significant. We measured the intracellular lipid content of liver samples and found that obese rats showed signs of non-alcoholic fatty liver disease, which were significantly ameliorated by SG. There were significantly higher glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide responses to a standard mixed meal in the SG group, as well as paradoxically higher glucagon secretion.
Conclusion
These data highlight the need for more specific anti-glucagon antibodies to characterize the changes in proglucagon-derived peptide concentrations that occur following SG. Further studies are required to determine whether these peptides contribute to the therapeutic effects of SG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Medicine, Kuwait University, Kuwait City, Kuwait, sulaiman.alsabah@ku.edu.kw.
- Department of Surgery, College of Medicine, Kuwait University, Kuwait City, Kuwait.
- Department of Organ Transplant, College of Medicine, Kuwait City, Kuwait.
- Department of Pharmacology and Toxicology, College of Medicine, Kuwait University, Kuwait City, Kuwait.
- Department of Pathology, College of Medicine, Kuwait University, Kuwait City, Kuwait.
- Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Kuwait City, Kuwait.
Zitieren
APA
Al-Sabah, S., Jamal, M. H., Al-Khaledi, G., Dsouza, C., AlOtaibi, F., Al-Ali, W., Cherian, P., Al-Khairi, I., Ali, H., Abu-Farha, M., Abubaker, J., & Al-Mulla, F. (2023). Increased Glucagon Immunoreactivity in a Rat Model of Diet-Induced Obesity following Sleeve Gastrectomy. Medical Principles and Practice. https://doi.org/10.1159/000533746
Vancouver
Al-Sabah S, Jamal MH, Al-Khaledi G, Dsouza C, AlOtaibi F, Al-Ali W, et al. Increased Glucagon Immunoreactivity in a Rat Model of Diet-Induced Obesity following Sleeve Gastrectomy. Medical Principles and Practice. 2023. doi:10.1159/000533746
BibTeX
@article{AlSabah2023,
author = {Al-Sabah, Suleiman and Jamal, Mohammad H and Al-Khaledi, Ghanim and Dsouza, Carol and AlOtaibi, Fatemah and Al-Ali, Waleed and Cherian, Preethi and Al-Khairi, Irina and Ali, Hamad and Abu-Farha, Mohamed and Abubaker, Jehad and Al-Mulla, Fahd},
title = {Increased Glucagon Immunoreactivity in a Rat Model of Diet-Induced Obesity following Sleeve Gastrectomy},
journal = {Medical Principles and Practice},
year = {2023},
doi = {10.1159/000533746}
}
EUVIMED